← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2016Last known activity
Oct 31, 2025
Timeline
2010s
- Jun 1, 2013
Union Therapeutics— Founded
Drugs by trial phase (20 distinct, 25 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- alpha 1-Antitrypsin Deficiency
- Bacterial Infections
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Congenital Abnormalities
- Dermatitis
- Dermatitis, Atopic
- Dermatitis, Contact
- Eczema
- Endometrial Neoplasms
- Impetigo
- Lung Neoplasms
- Melanoma
- Neoplasms
- Osteoarthritis
- Osteoarthritis, Knee
- Respiratory Aspiration
- Triple Negative Breast Neoplasms
Recent trials (31)
- NCT07142356OfficialPhase 2Oct 31, 2025
- NCT06205121OfficialPhase 2Mar 21, 2024
- NCT06194188OfficialPhase 2Dec 20, 2023
- NCT05983367Study directorPhase 2Oct 10, 2023
- NCT05848739Study chairPhase 1Jun 5, 2023
- NCT05469464Lead sponsorPhase 2Jul 11, 2022
- NCT05469464Study directorPhase 2Jul 11, 2022
- NCT05190419Study directorPhase 2Dec 30, 2021
- NCT05190419Lead sponsorPhase 2Dec 30, 2021
- NCT04982432CollaboratorPhase 2Oct 1, 2021
- NCT04932915Lead sponsorPhase 2Sep 3, 2021
- NCT05308953Study directorPhase 1May 6, 2021
- NCT04870333CollaboratorPhase 2/Phase 3Feb 19, 2021
- NCT04478279Study chairPhase 1/Phase 2Jul 1, 2020
- NCT04576312Study chairPhase 1Jun 29, 2020
Details
- Founded
- Hellerup, DK Jun 1, 2013
- Last known activity
- Oct 31, 2025
Notes
Formerly known as